Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC
about
Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?Epidemiology of diabetic retinopathy, diabetic macular edema and related vision lossEpigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular ComplicationsInsulin sensitivity and complications in type 1 diabetes: New insightsDisease modifying therapies in type 1 diabetes: Where have we been, and where are we going?Biomarkers in Diabetic RetinopathyNew Therapeutic Approaches in Diabetic Retinopathy.Long-lasting effect of obesity on skeletal muscle transcriptome.Further insight on the limits of success of glycemic control in type 1 diabetes.Lipotoxicity augments glucotoxicity-induced mitochondrial damage in the development of diabetic retinopathyIntensive diabetes therapy and ocular surgery in type 1 diabetes.Future opportunities in diabetic retinopathy research.The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.Reduced Histone H3 Acetylation in CD4(+) T Lymphocytes: Potential Mechanism of Latent Autoimmune Diabetes in AdultsAssociations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes.Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On StudyPeripheral Blood Mitochondrial DNA Damage as a Potential Noninvasive Biomarker of Diabetic RetinopathyThe Role of DNA Methylation in the Metabolic Memory Phenomenon Associated With the Continued Progression of Diabetic Retinopathy.Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.Health-system-based interventions to improve care in pediatric and adolescent type 1 diabetes.Retinal Failure in Diabetes: a Feature of Retinal Sensory Neuropathy.Epigenetic Changes in Diabetes and Cardiovascular Risk.Hyperglycaemic memory affects the neurovascular unit of the retina in a diabetic mouse model.Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.Clinical significance of 'cardiometabolic memory': a systematic review of randomized controlled trials.Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.Optimal screening schedules for disease progression with application to diabetic retinopathy.Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.Reduced Histone H3 Lysine 9 Methylation Contributes to the Pathogenesis of Latent Autoimmune Diabetes in Adults via Regulation of SUV39H2 and KDM4C.Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal Vessels.Proteome profiling in the aorta and kidney of type 1 diabetic rats.A blended link approach to relative risk regression.Diabetes-induced hyperglycemia impairs male reproductive function: a systematic review.ISPAD Guidelines. Managing diabetes in preschool children.Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.
P2860
Q26745523-F941EF2D-1D38-4EC1-A4BE-3C994A7AA08EQ26775552-EA79C8EE-50CE-4EE0-91A6-B3B42445CE95Q26859263-E61BE575-7A91-4821-AFC5-78A95A5710E8Q27000205-78E7152D-8B4A-4F11-ADCA-501A78774CA4Q28081034-ABDE8CAE-5B60-4CE0-AFEC-26269876C527Q33583030-9AF09469-FBF1-45DD-ABE8-A060EDCA7C4BQ33583037-E7983B9F-4BE7-4F58-9EF5-3E1DE5C8FF38Q33729970-141B72FA-4AFB-4E24-ABE8-786A64B22DD2Q35004364-319BF77B-068F-46A8-927A-E3B36B205D44Q35608796-2124503B-3715-464B-9BDE-E8948AD6A999Q35734567-692D463B-901F-4121-844D-38C6BAA1B817Q35935835-4EC102BA-2BF1-4400-A215-A63805734ED9Q36134684-21CF0606-C5CA-4645-8F11-3207CD7A5A96Q36453592-3B3AF8E4-EF11-46FF-9195-0F1068D66C57Q36503844-B82A4344-6CF4-454C-B49A-6FE248AEBA6BQ36820594-4C28CF69-9BE1-4358-A6C3-165601BDFAE4Q37025572-EC1D6B99-B7C2-46B0-9405-976DB5A1C87BQ37179655-CD9C69B3-F745-4A51-8805-B478616A5A0EQ37384357-D79356A5-C120-4502-9A8A-F8F200144822Q37728038-BDF7EF8E-8B76-4319-9A2E-6D4AB332D3E2Q38315999-B0329F3D-44FC-4841-ACB8-4FA15B9BBB33Q38365343-F1C550CE-E7FF-4929-80D3-2F6388E759EAQ38587713-717F70A2-8B05-4857-A688-88984B3C7117Q38605095-E26B1EBD-BAE6-4C34-BBFA-0DD5A89425AAQ38845518-01B30122-78F3-465F-BAC1-A17D70536D10Q38892115-06CBB1DB-E725-446B-966B-42819B7DB63FQ38972521-B873238F-3A4E-4934-9864-FCE551FE92ABQ39094213-A5190BAB-5CC1-4219-B74A-2DFC095B55CDQ40070444-B2D4A934-C409-4845-8B09-8520C3AE5848Q40232830-3A5C1879-3E9D-4959-8468-79AE145A6B31Q40236321-119B630C-0889-4783-A89C-173E10F1E8F0Q41787689-B96C4E0B-931E-4CA4-A660-9D455292D39FQ42115221-BAB7833E-D7AD-496A-9398-12A127CB6E3AQ42505245-BE963403-EFF5-4ADE-BB73-C40F7E0A36EBQ47151238-E09D9F9C-5050-438B-958B-783E9C2D667FQ47213637-E9EE5623-B251-4D8B-9079-182B4564D1BCQ47599535-F82ECCE8-44F9-4E3F-834A-2AC7D67B980EQ47774594-4CACCCDE-E922-4B11-8765-80631640C8DDQ47809831-2D7A64FF-7989-497E-9199-A4FAE25929EAQ47878608-DBAB50CB-34E1-4721-9272-E8DD39590405
P2860
Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effect of intensive diabetes t ...... of follow-up in the DCCT/EDIC
@ast
Effect of intensive diabetes t ...... of follow-up in the DCCT/EDIC
@en
type
label
Effect of intensive diabetes t ...... of follow-up in the DCCT/EDIC
@ast
Effect of intensive diabetes t ...... of follow-up in the DCCT/EDIC
@en
prefLabel
Effect of intensive diabetes t ...... of follow-up in the DCCT/EDIC
@ast
Effect of intensive diabetes t ...... of follow-up in the DCCT/EDIC
@en
P2093
P2860
P356
P1433
P1476
Effect of intensive diabetes t ...... of follow-up in the DCCT/EDIC
@en
P2093
David M Nathan
Dean P Hainsworth
Diabetes Control and Complicat ...... ications (EDIC) Research Group
Neil H White
Patricia A Cleary
Wanjie Sun
P2860
P304
P356
10.2337/DB14-0930
P407
P577
2014-09-09T00:00:00Z